Clinical features and prognosis of patients with COVID-19 after lung surgery: A retrospective clinical study

Asia Pac J Clin Oncol. 2021 Dec;17(6):555-560. doi: 10.1111/ajco.13517. Epub 2021 Feb 19.

Abstract

Aim: To evaluate whether the history of lung surgery in patients was associated with poor prognosis of coronavirus disease 2019 (COVID-19).

Methods: Clinical data of patients with COVID-19 in a single-center were retrospectively analyzed. Patients with and without lung surgery were matched in 1:4 ratio to compare the differences in clinical characteristics, laboratory results, computed tomography findings, treatment regimens, and prognosis between them.

Results: Four patients had a history of lung surgery. The time from surgery to COVID-19 onset ranged from 3 to 10 days, with a median of 6.75 days. The mortality rate in the surgical group was higher than that in the nonsurgical group (25.0% vs. 6.3%).

Conclusion: Patients contracting COVID-19 after lung surgery presented a higher death rate; hence, it is necessary to omit lung surgery in patients with active COVID-19 infection.

Keywords: coronavirus disease 2019; immunosuppression; lung cancer; lung function; lung surgery.

MeSH terms

  • COVID-19*
  • Humans
  • Lung
  • Prognosis
  • Retrospective Studies
  • SARS-CoV-2